UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 140

Sortiert nach

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

Neoplasia (New York, N.Y.), 2019-03, Vol.21 (3), p.282-293

2019

Volltextzugriff (PDF)

Dying at "home" - a qualitative study of end-of-life care in rural Northern Norway from the perspective of health care professionals

BMC health services research, 2023-12, Vol.23 (1), p.1359-1359, Article 1359

2023

Volltextzugriff (PDF)

Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer

Clinical cancer research, 2008-08, Vol.14 (16), p.5220-5227

2008

Volltextzugriff (PDF)

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer

British journal of cancer, 2021-05, Vol.124 (10), p.1680-1689

2021

Volltextzugriff (PDF)

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer

PloS one, 2018-02, Vol.13 (2), p.e0192157-e0192157

2018

Volltextzugriff (PDF)

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

Journal of thoracic oncology, 2011-04, Vol.6 (4), p.824-833

2011

Volltextzugriff (PDF)

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC

Scientific reports, 2019-07, Vol.9 (1), p.10163-11, Article 10163

2019

Volltextzugriff (PDF)

Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?

Cancer medicine (Malden, MA), 2013-08, Vol.2 (4), p.427-436

2013

Volltextzugriff (PDF)

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival

PloS one, 2014-09, Vol.9 (9), p.e105038-e105038

2014

Volltextzugriff (PDF)

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort

Oncotarget, 2017-04, Vol.8 (16), p.26789-26801

2017

Volltextzugriff (PDF)

Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non–small cell lung cancer

Human pathology, 2018-09, Vol.79, p.188-198

2018

Volltextzugriff (PDF)

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer

Oncotarget, 2016-11, Vol.7 (44), p.72184-72196

2016

Volltextzugriff (PDF)

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers

PloS one, 2015-08, Vol.10 (8), p.e0134965-e0134965

2015

Volltextzugriff (PDF)

Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer

Cancer, 2010-12, Vol.116 (24), p.5676-5685

2010

Volltextzugriff (PDF)

CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer

Neoplasia (New York, N.Y.), 2015-11, Vol.17 (11), p.839-848

2015

Volltextzugriff (PDF)

Evaluating a centralised cancer support centre in the remote region of Northern Norway

Rural and remote health, 2020-09, Vol.20 (3), p.1-7

2020

Volltextzugriff (PDF)

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer

PloS one, 2017-07, Vol.12 (7), p.e0181527-e0181527

2017

Volltextzugriff (PDF)

High progesterone receptor expression in prostate cancer is associated with clinical failure

PloS one, 2015-02, Vol.10 (2), p.e0116691

2015

Volltextzugriff (PDF)

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer

PloS one, 2012-01, Vol.7 (1), p.e29671-e29671

2012

Volltextzugriff (PDF)

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma

Frontiers in oncology, 2023, Vol.13, p.1157461-1157461

2023

Volltextzugriff (PDF)

Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

Carcinogenesis (New York), 2020-12, Vol.41 (12), p.1671-1681

2020

Volltextzugriff (PDF)

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases

Cancer Immunology, Immunotherapy, 2017-11, Vol.66 (11), p.1449-1461

2017

Volltextzugriff (PDF)

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence

Scientific reports, 2017-02, Vol.7 (1), p.43378-43378, Article 43378

2017

Volltextzugriff (PDF)

Prognostic impact of lymphocytes in soft tissue sarcomas

PloS one, 2011-01, Vol.6 (1), p.e14611-e14611

2011

Volltextzugriff (PDF)

Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer

Cancer, 2011-07, Vol.117 (14), p.3193-3200

2011

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(137)

Publikationsform

Artikel
(140)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Humans
(79)
Life Sciences & Biomedicine
(74)
Male
(65)
Oncology
(65)
Prognosis
(63)
Aged
(61)
Middle Aged
(61)
Vdp
(56)
Medical Disciplines: 700
(55)
Medisinske Fag: 700
(54)
Female
(52)
Tumors
(46)
Adult
(44)
Clinical Medical Disciplines: 750
(44)
Oncology: 762
(44)
Klinisk Medisinske Fag: 750
(43)
Onkologi: 762
(43)
Aged, 80 And Over
(38)
Carcinoma, Non-Small-Cell Lung - Pathology
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry

Dying at "home" - a qualitative study of end-of-life care in rural Northern Norway from the perspective of health care professionals

Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer

Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

Differential prognostic impact of platelet-derived growth factor receptor expression in NSCLC

Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?

Monocarboxylate transporters 1-4 in NSCLC: MCT1 is an independent prognostic marker for survival

The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort

Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non–small cell lung cancer

Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer

Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers

Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer

CD45RO+ Memory T Lymphocytes — a Candidate Marker for TNM-Immunoscore in Squamous Non–Small Cell Lung Cancer

Evaluating a centralised cancer support centre in the remote region of Northern Norway

The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer

High progesterone receptor expression in prostate cancer is associated with clinical failure

MicroRNA signatures in tumor tissue related to angiogenesis in non-small cell lung cancer

Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma

Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?

CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases

High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence

Prognostic impact of lymphocytes in soft tissue sarcomas

Independent and tissue‐specific prognostic impact of miR‐126 in nonsmall cell lung cancer

Suchergebnisse filtern